Hezong Medicine Easy-To-Buy Pharmaceutical establishes a subsidiary, Shutan Artificial Intelligence

According to the announcement from Zhitong Finance APP, Hezong Medicine Easy-To-Buy Pharmaceutical (300937.SZ) announced that its wholly-owned subsidiary Sichuan Hezong Medicine Easy-To-Buy Technology Group Co., Ltd. (referred to as "Hezong Medicine Technology Group") and Hangzhou Fuyiao Smart Technology Co., Ltd. (referred to as "Hangzhou Fuyiao") jointly invested to establish Sichuan Shutan Artificial Intelligence Technology Co., Ltd. (referred to as "Shutan Artificial Intelligence"), with a registered capital of 10 million yuan, funded by Hezong Medicine Technology Group and Hangzhou Fuyiao's own funds. The company holds 100% equity of Shutan Artificial Intelligence through its subsidiary, which has recently completed industrial and commercial registration and obtained a business license issued by the Administrative Approval Bureau of Jin Niu District, Chengdu.

The announcement stated that in response to the call of policies related to the development of the digital economy, the company is committed to building a collaborative, open, and diversified digital industrial ecosystem platform based on an AI digital intelligence system. The wholly-owned subsidiary Shutan Artificial Intelligence established by the company will rely on local government resource collaboration to integrate data resources such as digital supply chains, intelligent procurement and sales systems, and supply chain finance, using cutting-edge technologies such as artificial intelligence, big data, large models, the Internet of Things, and cloud computing to build a SaaS digital comprehensive service platform. This platform will carry out technical research and development and scenario application promotion of data resource operations covering basic data from upstream and downstream industries, cloud warehouse digital supply chains, and full network flow traceability systems for manufacturing enterprises